Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Drug Sponsors Should Include Women In QT Studies, CERT’s Woosley Says

Executive Summary

QT interval prolongation studies should include more women because of gender differences in cardiac sensitivity to drugs, University of Arizona Center for Education and Research on Therapeutics (AZCERT) Director Raymond Woosley said

You may also be interested in...

Drug Safety Pharmacy Database Pilot In Development Under FDA Partnership

A pilot program designed to track drug safety through a pharmacy-based electronic adverse event system is under development by the Critical Path to Accelerate Therapies Institute as part of a partnership with FDA

FDA Should Publish QT Prolongation Database, Industry Reps Say

Industry wants FDA to make available a database of results from QT prolongation studies

Antihistamine Forced Switch To OTC Endorsed By APhA Journal Editorial

A Journal of the American Pharmaceutical Association editorial endorses the forced switch of prescription antihistamines to over-the-counter status.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts